Safety study of LY03020 for healthy volunteers and people with schizophrenia
Part of Mental health clinical trials.
This study tests the safety of a new medication called LY03020. It is for healthy volunteers and for people with stable schizophrenia. The study aims to see how well the body handles the drug and what side effects might occur.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old (healthy volunteers) or 18 to 60 years old (if you have schizophrenia).
- You weigh at least 50 kg (men) or 45 kg (women) and have a BMI between 18.5 and 26 (healthy) or up to 32 (if you have schizophrenia).
- If you have schizophrenia, your symptoms must be stable and you must meet certain clinical scores.
- You cannot have significant medical conditions, eye problems, or a history of fainting when standing up.
- You cannot have used certain medications or supplements recently; for people with schizophrenia, some restrictions apply.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if LY03020 helps people with schizophrenia who are currently having a severe episode. If you have acute symptoms like hallucinations or delusions, this study could be an option.
This trial tests if a new drug called VV119 is safe and how it works in the body. It is for healthy volunteers and for people who have had schizophrenia for at least a year and are currently having worsening symptoms.
This trial studies how a new investigational drug (LY03017) moves through the body in younger adults and older adults, and whether food changes that. It will help researchers understand how to dose the medicine.
This trial tests a new medication called LB-102 for people with acute (sudden worsening of) schizophrenia. It aims to see if the drug helps reduce symptoms like hallucinations or disorganized thinking.
This is an early-stage study testing a new experimental drug called KR23248 in healthy volunteers to see if it is safe and how the body processes it. Researchers want to understand potential side effects and how the drug moves through your system.
This study tests the long-term safety of an investigational medication for schizophrenia over one year. It may be an option if you are currently stable on your antipsychotic medication.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.